Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes-Reference-Cited by-同舟云学术

Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes

Published:2020-08-07 Issue:21 Volume:126 Page:4735-4743
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Brierley Charlotte K.¹^ORCID,Zabor Emily C.²³,Komrokji Rami S.⁴,DeZern Amy E.⁵,Roboz Gail J.⁶,Brunner Andrew M.⁷,Stone Richard M.⁸,Sekeres Mikkael A.²³,Steensma David P.⁸^ORCID

Affiliation:

1. Weatherall Institute of Molecular Medicine Oxford United Kingdom

2. Department of Quantitative Health Sciences Cleveland Clinic Cleveland Ohio

3. Leukemia Program Taussig Cancer InstituteCleveland Clinic Cleveland Ohio

4. H. Lee Moffitt Cancer Center and Research Institute Tampa Florida

5. Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University Baltimore Maryland

6. Weill Cornell Medical College New York New York

7. Massachusetts General Hospital Harvard Medical School Boston Massachusetts

8. Dana‐Farber Cancer Institute Harvard Medical School Boston Massachusetts

Funder

Aplastic Anemia and MDS International Foundation

Edward P. Evans Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33105

Reference37 articles.

1. Biomarker-Driven Early Clinical Trials in Oncology

2. New clinical trial designs in the era of precision medicine

3. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples

4. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

5. Generalizability of cancer clinical trial results

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing catchment area tools: A de-identification method for integrating clinical trial data with Cancer InFocus;Preventive Oncology & Epidemiology;2024-08-17

2. Effects of socioeconomic status on enrollment in clinical trials for cancer: A systematic review;Cancer Medicine;2024-01

3. Access to cancer clinical trials for racialised older adults: an equity-focused rapid scoping review protocol;BMJ Open;2024-01

4. Comparison of survival outcomes between clinical trial participants and non-participants of patients with advanced non-small cell lung cancer: A retrospective cohort study;Heliyon;2023-12

5. Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS;Blood Reviews;2023-07